Status:
COMPLETED
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Lead Sponsor:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Conditions:
Retinal Diseases
Optic Nerve Diseases
Eligibility:
All Genders
38-42 years
Phase:
PHASE1
Brief Summary
Brief Summary The purpose of this study is to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct). This new technology provides a ver...
Eligibility Criteria
Inclusion
- Healthy term, gestational age of 38-42 weeks inclusive.
- Able to be transported to the Eye Clinic.
- No longer monitored. On no intravenous or other lines.
Exclusion
- History of hyperglycemia in the infant (a blood sugar greater than 100mg%, per Laboratory Policy on Critical Values for infants less than 20 days old).
- Feeding intolerance.
- Green-tinged aspirates/emesis.
- Abdominal distention.
- History of genetic consult indicating any abnormality.
- Any known ocular disorder.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01404247
Start Date
January 1 2011
End Date
December 1 2015
Last Update
July 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles Biomedical Research Institute atHarbor-UCLA Medical Center
Torrance, California, United States, 90502